Sysmex, a $2.5 billion Japanese maker of blood testing machines, is in the cross-hairs of Sight Diagnostics, an Israeli company that just received FDA approval for a blood tester that requires only two drops of blood.
Anti-Theranos: FDA Approval In Hand, Sight Diagnostics Aims At $2.7 Billion Blood Testing Giant, Sysmex
Forbes - 5 Dec 2019 17:03
Sysmex, a $2.5 billion Japanese maker of blood testing machines, is in the cross-hairs of Sight Diagnostics, an Israeli company that just received FDA approval for a blood tester that requires only two drops of blood.
Share this Article
Recommended